CASP3 and melanoma: We used human melanoma cells for first time over an extended period of time (24, 48, and 72h endpoints), compare their effects to those on adult human fibroblasts (48h endpoint) and in addition of caspase-3/7 we investigate their modulation of Bax/Bcl-2 expressions in order to gain further insights into their mechanisms of action.